Loxapine

Grey

Brand Name(s):Adasuve

Indication:Schizophrenia or bipolar disorder – mild-to-moderate agitation

Rationale:1

Considered:Jan-13

Review Date:Jul-23

Comments:
NICE technology appraisal 286
Loxapine inhalation for treating acute
agitation and disturbed behaviours
associated with schizophrenia and bipolar
disorder (terminated appraisal)
more info at:http://www.nice.org.uk/nicemedia/live/14172/63900/63900.pdf
Issued May 2013